Articles

When examining higher doses of tamoxifen and its second mechanism of action separate from estrogen receptors, researchers discovered the drug’s potential to fight aggressive, triple-negative breast cancer. Read More ›

Breast cancer patients may not metabolize tamoxifen well if they, along with patient-specific genetic factors, lack exposure to vitamin D during the winter months. Read More ›

Memory complaints among early-stage breast cancer patients who have undergone treatment are significantly linked to lower neuropsychological test performance. Read More ›

New research shows that cancer prevention beliefs differ between whites and minorities, including Asians, blacks, and Hispanics, and that minorities feel they are less likely than whites to develop cancer. Read More ›

Few breast cancer survivors follow national exercise recommendations of at least 150 minutes per week of moderate exercise during the 10 years following a diagnosis. Read More ›

In the first study of its kind to examine the human genome for predictors of chemotherapy side effects, researchers isolated gene variations with the potential to cause chemotherapy-induced peripheral neuropathy in patients. Read More ›

According to initial study results, cancerous tumors that have spread to the lungs are safely destroyed by cryoablation. Read More ›

When compared with other racial and ethnic groups across cancer subtypes, black women with breast cancer have significantly poorer survival, according to a recent study. Read More ›

Researchers surveyed survivors of breast, colorectal, gynecologic, and prostate cancers and found that when compared with the general adult population, cancer survivors have increased cardiovascular disease risk factors. Read More ›

Challenges prevail in the US population when it comes to transforming behaviors and risk factors related to cancer death. Read More ›